SLONIN JONATHAN 4
4 · Pacira BioSciences, Inc. · Filed Aug 2, 2024
Insider Transaction Report
Form 4
SLONIN JONATHAN
Chief Medical Officer
Transactions
- Tax Payment
Common Stock
2024-08-01$20.75/sh−305$6,329→ 95,251.746 total - Sale
Common Stock
2024-08-02$20.05/sh−945$18,947→ 94,306.746 total
Footnotes (2)
- [F1]Represents shares sold by the reporting person to cover tax obligations upon the vesting of restricted stock units.
- [F2]The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the reporting person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934.